Jeil Pharmaceutical Co Ltd (271980) — Free Cash Flow Generation Index
Jeil Pharmaceutical Co Ltd (271980) has a Free Cash Flow Generation Index of -3.20x as of December 2025. Free cash flow of ₩-1.70 Billion represents -3% of operating cash flow (₩532.03 Million). Explore how much does Jeil Pharmaceutical Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jeil Pharmaceutical Co Ltd Free Cash Flow Generation Index (2018–2024)
Historical FCF Generation Index trend for Jeil Pharmaceutical Co Ltd across 4 annual periods. For the full cash flow conversion analysis, see Jeil Pharmaceutical Co Ltd cash conversion from operations.
Annual Free Cash Flow Generation for Jeil Pharmaceutical Co Ltd (2018–2024)
Year-by-year Free Cash Flow Generation Index for Jeil Pharmaceutical Co Ltd. Check how aggressively does Jeil Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.06x | ₩-3.40 Billion | ₩3.21 Billion | ₩6.61 Billion | ▼ -247.4% |
| 2021 | 0.72x | ₩13.71 Billion | ₩19.10 Billion | ₩5.34 Billion | ▼ -24.6% |
| 2019 | 0.95x | ₩27.56 Billion | ₩28.96 Billion | ₩1.09 Billion | ▲ +82.9% |
| 2018 | 0.52x | ₩11.17 Billion | ₩21.45 Billion | ₩10.29 Billion | — |